Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in … – CNNMoney
Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in …CNNMoneyINDIANAPOLIS, June 10, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced that five abstracts featuring data from three clinical studies and separate pharmacology studies for its …and more »
[monetize id=”1″]
[monetize id=”2″]
Five things for pharma marketers to know: Wednesday, May 27 – Medical Marketing and Media
Medical Marketing and MediaFive things for pharma marketers to know: Wednesday, May 27Medical Marketing and MediaThis drug delivery technology could be used for insulin or injectable therapies that treat rheumatoid arthritis, psoriasis and multiple sclerosis, according to Reuters. Bayer announced in its first-quarter earnings call that it is weighing a …and more »